ResearcherUniversity of CopenhagenActive in the last 2 years
Dan Calatayud
Matched on ORCID iD 0000-0002-1844-7404; OpenAlex author ID A5055461734. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor survival in advanced pancreatic cancer. Co-author DOI 10.1016/j.ejca.2025.116095↗
- Prediction of Unresectability and Prognosis in Patients Undergoing Surgery on Suspicion of Pancreatic Cancer Using Carbohydrate Antigen 19-9, Interleukin 6, an… Co-author DOI 10.1097/mpa.0000000000001466↗
- Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. Co-author DOI 10.1038/bjc.2017.140↗
- Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers. Co-author DOI 10.1186/s40364-017-0087-6↗
- The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer. First author DOI 10.1002/ijc.30291↗
- MicroRNA biomarkers in whole blood for detection of pancreatic cancer. Co-author DOI 10.1001/jama.2013.284664↗
- Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer. Co-author DOI 10.1371/journal.pone.0067059↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Julia Sidenius Johansen · 6 shared papers, 2013–2020 · strength 0.38
- Paper Prediction of Unresectability and Prognosis in Patients Undergoing Surgery on Suspicion of Pancreatic Cancer Using Carb… DOI 10.1097/mpa.0000000000001466↗
- Paper Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocar… DOI 10.1186/s40364-017-0087-6↗
- Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
- Per Pfeiffer · 3 shared papers, 2013–2025 · strength 0.33
- Paper Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor surv… DOI 10.1016/j.ejca.2025.116095↗
- Paper The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer. DOI 10.1002/ijc.30291↗
- Paper Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer. DOI 10.1371/journal.pone.0067059↗
- I.M. Chen · 1 shared paper, 2025 · strength 0.26
- Astrid Zedlitz Johansen · 1 shared paper, 2025 · strength 0.26
- Gunilla Høyer‐Hansen · 1 shared paper, 2025 · strength 0.26
- Rikke Løvendahl Eefsen · 1 shared paper, 2025 · strength 0.26
- Nicolai A. Schultz · 5 shared papers, 2013–2017 · strength 0.24
- Paper Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocar… DOI 10.1186/s40364-017-0087-6↗
- Paper Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. DOI 10.1038/bjc.2017.140↗
- Paper The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer. DOI 10.1002/ijc.30291↗
- Carsten Palnæs Hansen · 2 shared papers, 2017–2020 · strength 0.20
- Paper Prediction of Unresectability and Prognosis in Patients Undergoing Surgery on Suspicion of Pancreatic Cancer Using Carb… DOI 10.1097/mpa.0000000000001466↗
- Paper Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocar… DOI 10.1186/s40364-017-0087-6↗
- Jens Werner · 3 shared papers, 2013–2017 · strength 0.15
- Paper Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocar… DOI 10.1186/s40364-017-0087-6↗
- Paper The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer. DOI 10.1002/ijc.30291↗
- Paper Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer. DOI 10.1371/journal.pone.0067059↗
- Camilla Palmquist · 1 shared paper, 2020 · strength 0.13
- Klaus Kaae Andersen · 2 shared papers, 2014–2016 · strength 0.09
- Nathalia A. Giese · 2 shared papers, 2013–2016 · strength 0.08
- Jon Kroll Bjerregaard · 2 shared papers, 2013–2014 · strength 0.07
- Anders Molven · 1 shared paper, 2017 · strength 0.07
- Jonas Schnittert · 1 shared paper, 2017 · strength 0.06
- Carlos Fernández Moro · 1 shared paper, 2017 · strength 0.06
- Rainer Lothar Heuchel · 1 shared paper, 2017 · strength 0.06
- Carina Strell · 1 shared paper, 2017 · strength 0.06
- Artur Mezheyeuski · 1 shared paper, 2017 · strength 0.06
- Praneeth Reddy Kuninty · 1 shared paper, 2017 · strength 0.06
- Arne Östman · 1 shared paper, 2017 · strength 0.06
- Jai Prakash · 1 shared paper, 2017 · strength 0.06
- Matthias J. Löhr · 1 shared paper, 2017 · strength 0.06
- Caroline Sophie Verbeke · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.